Drug search by name

Olumiant and Tuberculosis

Result of checking the interaction of drug Olumiant and disease Tuberculosis for safety when used together.

Check result:

Olumiant <> Tuberculosis

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Baricitinib should not be given to patients with active tuberculosis (TB). Evaluate and test patients for latent or active infection before administering this agent. Consider anti-TB therapy prior to initiating treatment with baricitinib in patients with a history of latent or active TB in whom an adequate course of treatment cannot be confirmed, and for patients with a negative test for latent TB but who have risk factors for TB infection. Consultation with a physician with expertise in the treatment of TB is recommended to aid in the decision about whether initiating anti-TB therapy is appropriate for an individual patient. Patients with latent TB should be treated with standard antimycobacterial therapy before initiating treatment. Monitor patients for the development of signs and symptoms of TB, including patients who tested negative for latent TB infection prior to initiating therapy.

Olumiant

Generic Name: baricitinib

Brand Name: Olumiant

Synonyms: n.a.

What is Olumiant?